Inhaltsverzeichnis
News
03.08.2022 GBG-Research at EMSO 2022
We are proud to present our research at ESMO Congress 2022 in Paris.
Mehr ...14.07.2022 Eight-year data from APHINITY study presented
Eight-year data from APHINITY study show Roche’s Perjeta-based regimen continues to reduce the risk of disease returning for people with HER2-positive early breast cancer
Mehr ...24.05.2022 Ovarian Toxicity Assessment
In a paper in "The Breast" we discuss the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials.
Mehr ...